FDA inspection
Novartis Manufacturing NV: FDA inspection ending Apr 29, 2021
FDA inspection 1152317 · Voluntary Action Indicated (VAI) · Puurs-Sint-Amands
Key facts
| Inspection ID | 1152317 |
|---|---|
| Firm | Novartis Manufacturing NV |
| FEI number | 3002037047 |
| Address | Rijksweg 14 |
| City | Puurs-Sint-Amands |
| Country | Belgium |
| Fiscal year | 2021 |
| Inspection end date | Apr 29, 2021 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data